Going to Bio-IT World? BullFrog AI is exhibiting our technology for drug discovery and clinical development. Stop by our booth to learn how we generate insights for drug target identification and validation, and support clinical trial optimization using predictive biomarkers for efficacy and safety. #AIinDrugDiscovery #BioITExpo #BullFrogAI #TechBio #DataScience #Bioinformatics
BullFrog AI
Biotechnology Research
Gaithersburg, Maryland 2,608 followers
Leap Into the Future of Drug Development With BullFrog AI
About us
BullFrog AI (NASDAQ: BFRG) is a technology-enabled life science company using advanced artificial intelligence (AI) to usher in the next generation of lifesaving therapies. With our leading-edge platform, bfLEAP™, we aid in accelerating and de-risking drug discovery and clinical development using one of the industry’s most advanced graph analytic AI technologies. The Problem: The drug development landscape is littered with failed products and unrealized ROI — all while patients are desperately waiting for treatments that often don’t come: • The cost of bringing a drug to market is $.8 to $2.8 billion • Almost 90% of drugs don’t get there • The average time to market is 8.5 YEARS Our Solution: We’re applying machine learning and AI in drug development to identify new potential therapeutic targets, optimize clinical trials, rescue and repurpose drugs for new indications, and discover new drug targets. By identifying hidden relationships in clinical data, we aim to mitigate risk and elevate the trajectory of precision medicine. Our Technology: The bfLEAP™ platform delivers in a way that neural network models cannot: Explainable AI. We use network models in an interactive graph machine learning format to display and explain your data insights with confidence. Say goodbye to “black box” processing and say hello to AI outputs you can explore and understand. Join Us in Our Mission: With our platform’s superior capabilities, a high-powered team of industry experts, and a pipeline of exclusive in-licensed assets for clinical development, BullFrog AI is pushing the boundaries of AI-assisted drug development. Make BullFrog AI an extension of your organization and clear your analytical barriers. Leap into the next generation of drug development with BullFrog AI.
- Website
-
http://bullfrogai.com
External link for BullFrog AI
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Gaithersburg, Maryland
- Type
- Public Company
- Founded
- 2017
- Specialties
- AI, Data Analysis, and bfLEAP
Locations
-
Primary
Get directions
Gaithersburg, Maryland 20878, US
-
Get directions
432 State St
Annapolis, MD 21403, US
Employees at BullFrog AI
-
Joseph Koffenberger
Helping companies leverage information technologies for competitive advantage and better security.
-
Juan Felipe Beltrán Lacouture, Ph.D.
Director of AI, Machine Learning, and Innovation @ BullFrog AI 💊🏥 | Specialist in Multidisciplinary Teams, Algorithms, and Computational Biology
-
Thomas Hazel
Drug development professional with expertise in cell-based therapies & regenerative medicine
Updates
-
BullFrog AI reposted this
BullFrog AI is looking forward to exhibiting at Bio-IT World in April! Discover how BullFrog Data Networks® can support target identification and validation with reduced risk, cost and time. Contact us to set up a time to share our demo in Boston. We look forward to helping you achieve your next milestones. #AIinDrugDiscovery #BioITExpo https://lnkd.in/dCf9Sz5
-
-
BullFrog AI reposted this
How is AI transforming drug development? Toby Sayre of BullFrog AI shares how their AI-driven approach enhances decision-making, accelerates therapeutic innovation, and improves success rates. In this interview, he discusses Bullfrog AI’s technology, its impact on the future of drug development, and the company’s experience as a sponsor at RESI. 🔗 Learn more here: https://lnkd.in/e_gEkhv2 #AI #DrugDevelopment #Innovation #RESI
-
BullFrog AI reposted this
Are TechBios the missing piece of the puzzle to bring biotech to the next level? 💡 We are seeing more and more deals between biopharma companies and AI-driven companies: TechBios. But what are these companies doing and can they actually change the industry? 🤔 To better understand this TechBio movement, Labiotech reached out to Vin Singh, founder, and CEO of BullFrog AI, a TechBio with a proprietary AI platform gaining traction in biotech. 🤖 How do these companies operate, what do they bring to their biotech partners, and what does the future look like for them? We asked these questions to Vin – read his answers in our latest article! ⬇️ https://lnkd.in/djyzJ8Kh #AIinBiotech #techbio #biotechinnovation #machinelearning #futureofbiotech #biotechtrends #healthcaretech
-
BullFrog AI reposted this
https://lnkd.in/dadmTYbD “There’s so much concern about the cost of healthcare,” says Vin Singh, the CEO of a technology company named BullFrog AI. BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.....
-
BullFrog AI reposted this
Helping companies leverage information technologies for competitive advantage and better security.
Here's a great article that speaks to our efforts here at BullFrog AI. Give it a read!
https://lnkd.in/dadmTYbD “There’s so much concern about the cost of healthcare,” says Vin Singh, the CEO of a technology company named BullFrog AI. BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.....
-
BullFrog AI reposted this
https://lnkd.in/dadmTYbD “There’s so much concern about the cost of healthcare,” says Vin Singh, the CEO of a technology company named BullFrog AI. BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.....
-
https://lnkd.in/dadmTYbD “There’s so much concern about the cost of healthcare,” says Vin Singh, the CEO of a technology company named BullFrog AI. BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.....
-
BullFrog AI is looking forward to exhibiting at Bio-IT World in April! Discover how BullFrog Data Networks® can support target identification and validation with reduced risk, cost and time. Contact us to set up a time to share our demo in Boston. We look forward to helping you achieve your next milestones. #AIinDrugDiscovery #BioITExpo https://lnkd.in/dCf9Sz5
-
-
https://lnkd.in/eVcbB6XV GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its entry into a collaboration agreement with Eleison Pharmaceuticals Inc. (“Eleison”), a Phase 3 oncology company focused on novel chemotherapeutic treatments for rare cancers. Under the terms of the agreement, BullFrog AI will provide access to its BullFrog Data Networks™ AI solution to enhance clinical trial efficiency and patient insights. Financial terms of the collaboration were not disclosed.